Related Experiment Video
Updated: May 1, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
[Cognitive function in breast cancer patients on chemotherapy: a longitudinal study]
Xingui Chen1, Jingjing Li, Chunyan Zhu
1Department of Neurology, First Affiliated Hospital, Anhui Medical University, Hefei 230032, China.
Objective:
To explore whether cognitive impairment in breast cancer patients after the completion of chemotherapy treatment in comparisons with breast cancer patients without chemotherapy treatment and matched healthy controls.
Methods:
A neuropsychology battery was applied in all breast cancer patients at our hospital from January 2012 to February 2013. Forty-two breast cancer patients with chemotherapy treatment (CT) underwent neuropsychologic testing before the start of chemotherapy (T1) and after treatment (T2). And 37 patients without chemotherapy treatment (non-CT) and matched healthy controls (HC) underwent the same assessment at matched intervals.
Results:
The CT group performed significantly worse on attention, memory and executive function tests at T2 versus T1 (P < 0.05). As compared with HC and non-CT groups, the correct numbers of backward, digit symbol, delayed recall and recognition were lower in the CT group (P < 0.05). The reacting time of TMT test B, Stroop test B and Stroop test C were longer in the CT group (P < 0.05). There was significant time interaction in three groups (P < 0.05).
Conclusion:
There are longitudinal changes in cognitive functioning of memory, attention and executive functions in breast cancer patients on Chemotherapy.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Longitudinal Research